The obligation of transparency imposes amongst others pharmaceutical and medical devices companies, both Belgian and foreign, to document and annually publicise the premiums and benefits that they grant directly or indirectly to healthcare professionals, healthcare organisations or patient organisations (“beneficiaries”).

If the beneficiary has a practice or a registered office in Belgium, the documentation and publication of the premiums and benefits must be done in the Belgian Transparency Register of (regardless of where the company is established).